Status:
UNKNOWN
Usefulness of Non TNF Usage in RA Patients
Lead Sponsor:
Shinshu University
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
20-100 years
Phase:
PHASE2
Brief Summary
The aim of this study is to examine the efficacy and adverse events in the following 3 groups in rheumatoid arthritis patients: 1. Sarilumab treatment for 12 months 2. Tocilizmab treatment for 12 mon...
Eligibility Criteria
Inclusion
- ・RA patients
Exclusion
- Not RA patients
- RA patients who are allergic to the drugs, refused to do this research, or who are pregnant
Key Trial Info
Start Date :
December 17 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 16 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03784261
Start Date
December 17 2018
End Date
December 16 2024
Last Update
September 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yukio Nakamura
Matsumoto, Nagano, Japan, 3908621